Display options
Share it on

J Ovarian Res. 2012 Nov 07;5(1):32. doi: 10.1186/1757-2215-5-32.

Gonadotropin treatment augments postnatal oogenesis and primordial follicle assembly in adult mouse ovaries?.

Journal of ovarian research

Deepa Bhartiya, Kalpana Sriraman, Pranesh Gunjal, Harshada Modak

Affiliations

  1. Stem Cell Biology Department, National Institute for Research in Reproductive Health, Mumbai, 400 012, India. [email protected].

PMID: 23134576 PMCID: PMC3616927 DOI: 10.1186/1757-2215-5-32

Abstract

BACKGROUND: Follicle stimulating hormone (FSH) exerts action on both germline and somatic compartment in both ovary and testis although FSH receptors (FSHR) are localized only on the somatic cells namely granulosa cells of growing follicles and Sertoli cells in the seminiferous tubules. High levels of FSH in females are associated with poor ovarian reserve, ovarian hyper stimulation syndrome etc. and at the same time FSH acts as a survival factor during in vitro organotypic culture of ovarian cortical strips. Thus a further understanding of FSH action on the ovary is essential. We have earlier reported presence of pluripotent very small embryonic-like stem cells (VSELs express Oct-4A in addition to other pluripotent markers) and their immediate descendants 'progenitors' ovarian germ stem cells (OGSCs express Oct-4B in addition to other germ cell markers) in ovarian surface epithelium (OSE) in various mammalian species including mice, rabbit, monkey, sheep and human. Present study was undertaken to investigate the effect of pregnant mare serum gonadotropin (PMSG) on adult mice ovaries with a focus on VSELs, OGSCs, postnatal oogenesis and primordial follicle assembly.

METHODS: Ovaries were collected from adult mice during different stages of estrus cycle and after 2 and 7 days of PMSG (5 IU) treatment to study histo-architecture and expression for FSHR, pluripotent stem cells , meiosis and germ cell specific markers.

RESULTS: PMSG treatment resulted in increased FSHR and proliferation as indicated by increased FSHR and PCNA immunostaining in OSE and oocytes of primordial follicles (PF) besides the granulosa cells of large antral follicles. Small 1-2 regions of multilayered OSE invariably associated with a cohort of PF during estrus stage in control ovary were increased to 5-8 regions after PMSG treatment. This was associated with an increase in pluripotent transcripts (Oct-4A, Nanog), meiosis (Scp-3) and germ cells (Oct-4B, Mvh) specific markers. MVH showed positive immuno staining on germ cell nest-like clusters and at places primordial follicles appeared connected through oocytes.

CONCLUSIONS: The results of the present study show that gonadotropin (PMSG) treatment to adult mouse leads to increased pluripotent stem cell activity in the ovaries, associated with increased meiosis, appearance of several cohorts of PF and their assembly in close proximity of OSE. This was found associated with the presence of germ cell nests and cytoplasmic continuity of oocytes in PF. We have earlier reported that pluripotent ovarian stem cells in the adult mammalian ovary are the VSELs which give rise to slightly differentiated OGSCs. Thus we propose that gonadotropin through its action on pluripotent VSELs augments neo-oogenesis and PF assembly in adult mouse ovaries.

References

  1. Endocr Relat Cancer. 2006 Jun;13(2):641-51 - PubMed
  2. Hum Reprod. 1999 Jun;14(6):1555-62 - PubMed
  3. Stem Cells Dev. 2012 Jan;21(1):1-6 - PubMed
  4. Mol Cell Biol Res Commun. 1999 Jul;2(1):21-7 - PubMed
  5. Aging (Albany NY). 2009 Dec 12;1(12):971-8 - PubMed
  6. Endocrinology. 2006 May;147(5):2338-45 - PubMed
  7. Endocrinology. 2001 Jan;142(1):381-9 - PubMed
  8. Mech Dev. 2000 May;93(1-2):139-49 - PubMed
  9. Ann N Y Acad Sci. 2010 Sep;1205:5-11 - PubMed
  10. Nature. 2004 Mar 11;428(6979):145-50 - PubMed
  11. Mol Hum Reprod. 2006 May;12(5):283-9 - PubMed
  12. Mol Cell Endocrinol. 2001 Feb 14;172(1-2):213-22 - PubMed
  13. Nat Med. 2012 Feb 26;18(3):413-21 - PubMed
  14. Dev Biol. 2003 Oct 15;262(2):303-12 - PubMed
  15. Differentiation. 2010 Mar;79(3):159-70 - PubMed
  16. Fertil Steril. 2009 May;91(5 Suppl):1967-75 - PubMed
  17. Reprod Biomed Online. 2004 Apr;8(4):385-91 - PubMed
  18. Int J Cancer. 2004 Dec 10;112(5):803-14 - PubMed
  19. Anat Rec (Hoboken). 2011 Aug;294(8):1284-306 - PubMed
  20. Cancer Res. 2001 Sep 15;61(18):6768-76 - PubMed
  21. Biol Reprod. 2012 Jul 05;87(1):3, 1-11 - PubMed
  22. J Clin Endocrinol Metab. 2000 Jan;85(1):270-4 - PubMed
  23. Reproduction. 2001 Mar;121(3):455-61 - PubMed
  24. J Clin Endocrinol Metab. 2002 May;87(5):2245-53 - PubMed
  25. Biol Reprod. 2004 Nov;71(5):1501-7 - PubMed
  26. Reprod Sci. 2013 Jan;20(1):7-15 - PubMed
  27. Oncol Res. 2008;17(5):231-8 - PubMed
  28. Differentiation. 2008 Oct;76(8):843-56 - PubMed
  29. Hum Reprod. 2012 Mar;27(3):938; author reply 938-9 - PubMed
  30. Biol Reprod. 1994 Nov;51(5):821-30 - PubMed
  31. Stem Cells Dev. 2011 Aug;20(8):1451-64 - PubMed
  32. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12580-5 - PubMed
  33. Cytometry A. 2009 Jan;75(1):4-13 - PubMed
  34. Curr Biol. 2003 Dec 2;13(23):2110-7 - PubMed
  35. BMC Dev Biol. 2003 Mar 19;3:1 - PubMed
  36. Clin Cancer Res. 2000 Jul;6(7):2764-70 - PubMed
  37. Reprod Biol Endocrinol. 2004 Apr 28;2:20 - PubMed
  38. Stem Cells Dev. 2012 Mar 20;21(5):670-4 - PubMed
  39. Am J Pathol. 1996 Jan;148(1):47-53 - PubMed
  40. Curr Pharm Des. 2012;18(3):283-92 - PubMed
  41. Gene Expr Patterns. 2005 Jun;5(5):639-46 - PubMed
  42. Endocrinology. 1979 Oct;105(4):960-6 - PubMed
  43. Am J Pathol. 2009 Jun;174(6):1985-92 - PubMed
  44. Endocrinology. 2000 Dec;141(12):4449-56 - PubMed
  45. Int J Cancer. 2003 Jan 20;103(3):328-34 - PubMed
  46. Mol Cell Endocrinol. 2007 Jan 2;260-262:163-71 - PubMed
  47. Hum Reprod. 2011 Aug;26(8):2129-39 - PubMed
  48. J Clin Endocrinol Metab. 2002 May;87(5):2266-76 - PubMed
  49. Reproduction. 2012 Feb;143(2):139-49 - PubMed
  50. Stem Cell Rev Rep. 2010 Jun;6(2):307-16 - PubMed
  51. J Cell Physiol. 2004 Jan;198(1):119-24 - PubMed
  52. Genome Biol. 2000;1(3):REVIEWS1017 - PubMed
  53. Mol Cell Endocrinol. 2007 Mar 15;267(1-2):26-37 - PubMed
  54. J Reprod Immunol. 2007 Jun;74(1-2):24-33 - PubMed
  55. Int J Gynecol Pathol. 2005 Apr;24(2):153-63 - PubMed
  56. Gynecol Endocrinol. 1999 Apr;13(2):75-81 - PubMed
  57. Mol Cell Endocrinol. 2001 Apr 25;175(1-2):29-39 - PubMed
  58. Reproduction. 2006 Jul;132(1):95-109 - PubMed
  59. J Reprod Fertil. 1986 May;77(1):287-96 - PubMed
  60. Reprod Sci. 2008 Feb;15(2):139-46 - PubMed
  61. Biol Reprod. 2010 Jan;82(1):13-22 - PubMed
  62. Endocr Rev. 2007 Jun;28(4):440-61 - PubMed
  63. J Clin Endocrinol Metab. 2004 Nov;89(11):5508-16 - PubMed
  64. J Histochem Cytochem. 2010 Dec;58(12):1093-106 - PubMed
  65. Chromosome Res. 2004;12(3):197-213 - PubMed
  66. Obstet Gynecol Int. 2012;2012:921082 - PubMed
  67. Hum Reprod Update. 1997 May-Jun;3(3):281-95 - PubMed
  68. J Biol Chem. 2006 Nov 3;281(44):33554-65 - PubMed
  69. Nat Med. 2012 Mar 06;18(3):353-4 - PubMed
  70. Endocr Rev. 2009 Aug;30(5):465-93 - PubMed
  71. Hum Reprod. 1986 Feb;1(2):81-7 - PubMed
  72. Cell Cycle. 2008 Mar 1;7(5):683-6 - PubMed
  73. Nat Cell Biol. 2009 May;11(5):631-6 - PubMed
  74. Biol Reprod. 2012 Oct 04;87(4):80 - PubMed

Publication Types